Lymphoma & Plasma Cell Disorders
    
    
  
  News
FDA approves daratumumab split-dosing regimen in MM
The split-dose regimen resulted in a similar rate of infusion site reactions.
From the Journals
Anthracyclines, bendamustine are options for grade 3A follicular lymphoma
A CVP chemotherapy regimen performed poorly compared with anthracycline-based chemotherapy in advanced stage follicular lymphoma.
From the Journals
Ibrutinib-MTX-rituximab combo shows promise in CNS lymphoma
The researchers proposed an 840-mg dose of ibrutinib in future studies.
From the Journals
Daratumumab disappoints in non-Hodgkin lymphoma trial
The drug, used in multiple myeloma, was safe but ineffective in patients with non-Hodgkin lymphoma.
From the Journals
BCL expression intensity key in distinguishing FL lesions
BCL2 expression intensity is the “single most valuable clue” in differentiating primary cutaneous follicular center-cell lymphoma from secondary...
From the Journals
Trial supports less aggressive myeloma treatment
A less intensive transplant and maintenance strategy proved equally effective as more aggressive approaches in patients with multiple myeloma.
From the Journals
Combo appears to overcome aggressive L-NN-MCL
Two case studies highlight the role that P53 gene status plays in prognosis and treatment.
Conference Coverage
Increased risk of second cancers in mycosis fungoides
LA JOLLA, CALIF. – Researchers found the risk of second malignancy was highest among MF patients aged 30 to 50 years and patients who had tumor...
News
FDA: 246 new reports on breast implant-associated lymphoma
The latest update from the Food and Drug Administration includes medical device reports between September 2017 and September 2018.
Conference Coverage
Cobomarsen shows early promise for treating ATLL
LA JOLLA, CALIF. – A small number of patients experienced disease stabilization or regression on cobomarsen.
Conference Coverage
Cerdulatinib yields ‘encouraging’ results in CTCL, PTCL
LA JOLLA, CALIF. – Some CTCL patients experienced relief from itching after just one pill.